WebCytokine PharmaSciences, Inc., is a privately held, global biopharmaceutical company … WebCytokine inhibitors; HIV replication inhibitors; Immunomodulators; Interleukin 1 inhibitors; Interleukin 6 inhibitors; Mitogen-activated protein kinase inhibitors; Nitric oxide inhibitors; Raf kinase inhibitors; RNA inhibitors; Tumour necrosis factor alpha inhibitors; Tumour necrosis factor inhibitors Orphan Drug Status
Cytokine Pharmasciences, Inc. - Montgomery PA, Seattle WA, …
In a preclinical study in rats, semapimod was found to suppress cytokine-storm induction by the anticancer cytokine interleukin-2 (IL-2) without decreasing its anticancer properties, allow larger doses of IL-2 to be administered. A subsequent phase I trial in humans failed to show an increase in the tolerated dose of IL-2, although indications of pharmacological activity as an inhibitor of tumor necrosis factor production were observed. WebCytokine PharmaSciences is developing semapimod (CNI-1493), a cytokine inhibitor … church of jesus christ primary activities
Dennis Willson, JD – Melmark
WebFerring Pharmaceuticals announced today that it has completed the purchase of Cytokine PharmaSciences Inc. (CPSI) and its UK subsidiary Controlled Therapeutics (Scotland) Ltd. (CTS), a global biopharmaceutical company with a particular focus in obstetrics. WebHe was formerly the President & CEO of Cytokine PharmaSciences, Inc., a … WebOct 9, 2024 · Semapimod ® (cytokine, pharmasciences) Semapimod ® is a synthetic guanylhydrazone that inhibits 1) signal transduction pathways by preventing phosphorylation of p38 MAP kinase and JNK; 2) production of the proinflammatory cytokines TNF-alpha, IL-1, IL-6. MIP-1 alpha, MIP-1 beta; and 3) production of nitric oxide. church of jesus christ photo release